Stefan Franz Thomas Weiss,Katarina Jovanovic,Danielle Gonsavles,Bianca Da Costa Dias,Stefan Knackmuss,Uwe Reusch,Melvyn Little,Marc Saul Weinberg
申请号：
US15150958
公开号：
US20160361413A1
申请日:
2016.05.10
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to a method of modulating concentration of Alzheimers Disease (AD) relevant proteins amyloid precursor protein (APP), beta (β) and gamma (γ) secretases and amyloid beta peptide (Aβ), and also relates to a method of reducing Aβ shedding. Furthermore, this invention extends to a compound for use in the treatment of AD, and also to a method of treating AD.
